Perimeter Medical Imaging AI Partners with Jennifer Douglas to Advance Breast Cancer Advocacy
Partnership for Change in Breast Cancer
Perimeter Medical Imaging AI, a prominent player in the medical technology sector, is excited to announce its recent partnership with Jennifer Douglas, a notable advocate for breast cancer patients. This collaboration aims to enhance patient engagement and education initiatives, an area where Douglas has made significant strides in her career.
Jennifer Douglas: A Voice for Patients
Jennifer Douglas is not just a breast cancer survivor; she's a passionate advocate who has made it her mission to support others facing similar battles. Diagnosed with Ductal Carcinoma In Situ (DCIS), Douglas intimately understands the challenges faced by breast cancer patients. Her personal journey, filled with daunting decisions and emotional hurdles, inspired her to write the book A Breast Cancer Journey: Living it One Step at a Time. Through her writings and community engagement, she seeks to transform the experience of others in the breast cancer community.
Douglas's commitment to advocacy led her to establish the Encourage community, providing support to patients undergoing treatment and navigating survivorship. Her leadership extends to running both virtual and in-person support sessions for the California Breast Cancer Support Group, further amplifying her impact on patient care and emotional resilience.
Enhancing Patient Engagement
With her exceptional background, Douglas joins Perimeter Medical Imaging's Industry Advisory Board, where she will focus on vital patient education initiatives. Her insights are anticipated to significantly influence how the company engages with breast cancer patients. “Breast cancer surgery is not only physically daunting but also emotionally taxing,” Douglas noted. “Innovative technologies like Perimeter's OCT-based imaging platform can truly transform the patient experience by minimizing complications and optimizing recovery times.”
The purpose of this partnership goes beyond mere advocacy; it aims to create real-world solutions for improving quality of life among patients. Douglas's voice, shaped by her personal journey and professional expertise, is expected to guide Perimeter's strategy in a way that resonates deeply with patients.
The Perimeter Mission
Perimeter Medical Imaging is dedicated to revolutionizing cancer surgery through advanced imaging solutions. Based in Toronto and Dallas, the company offers its FDA-cleared Perimeter S-Series OCT system, which provides real-time, cellular-level imagery of excised tissues. This innovative system has the potential to reduce re-excision rates, a significant concern for patients aiming to avoid multiple surgeries.
Currently, Perimeter is also evaluating its next-generation imaging technology, the Perimeter B-Series, integrated with ImgAssist AI, in pivotal clinical trials backed by substantial funding from the Cancer Prevention and Research Institute of Texas. This showcases the company's commitment to pushing the boundaries of cancer surgery technology in pursuit of better patient outcomes.
Through this partnership, both Perimeter and Douglas aim to not only improve surgical outcomes but also enhance the emotional and support frameworks that surround breast cancer treatment. Douglas's authentic desire to foster a supportive community will synergize beautifully with Perimeter's technology-driven initiatives.
Conclusion: A Future of Hope
As this collaboration unfolds, the shared vision between Perimeter Medical Imaging AI and Jennifer Douglas stands as a beacon of hope for breast cancer patients. Their combined efforts aim to foster a more informed and supportive environment for individuals navigating the complexities of cancer treatment, ultimately leading to enhanced recovery and quality of life. For those affected by breast cancer, this partnership signifies a commitment to innovation, compassion, and most importantly, progress in the face of adversity.